1 Prohibits to Import, manufacture, sale, distribution and use in any food producing animal rearing system of drug formulations containing 'Chloramphenicol or Nitrofurans drugs with immediate effect 2

4

==> picture [142 x 10] intentionally omitted <==

----- Start of picture text -----<br> F.No:VET-13020(20)/3/2026-32711<br>----- End of picture text -----<br>

Government of India

Ministry of Health and Family Welfare

Directorate General of Health Services Central Drugs Standard Control Organization (Veterinary Division)

==> picture [11 x 17] intentionally omitted <==

----- Start of picture text -----<br> To<br>----- End of picture text -----<br>

All States /UTs Durgs Controllers,

==> picture [106 x 48] intentionally omitted <==

----- Start of picture text -----<br> FDA Bhawan Kotla Road,<br>New Delhi-110 002, India,<br>) 3 JUN 90%<br>----- End of picture text -----<br>

Subject: Prohibits to Import, manufacture, sale, distribution and use in any food producing animal rearing system of drug formulations containing "Chloramphenicol! or Nitrofurans drugs with imediate effect.reg

Ref: This office letter vide No.: DC-DT-13011(11)/11/2024-16346 dt. 02.04.2025.

Sir/Madam,

This is in continuation to this office letter vide above reference, wherein it was requested to sensitise your inspectorate staff to keep vigil on manufacture, sale and distribution of Chloramphenicol and its formulations and Nitrofuran and its formulations in any food-producing animal rearing system and requested to inform details of actions taken. (Copy enclosed)

That, this office is in receipt of a letter dt. 27.01.2026 (copy enclosed) from the Director, MPEDA mentioning that despite Notification S.O. 1158 dated 12.03.2025 banning Chloramphenicol! and Nitrofurans and their formulations, residues continue to be detected in shrimp export consignments, leading to 43% rejections in 2025 by the EU, USA, and Japan, which is linked to more than 40 farms from various States predominantly located in Andhra Pradesh (74%), Odisha (13%), West Bengal (8.7%), and Gujarat (4.3%). It mentioned the importance of effective inspection and audits of Veterinary medical shops, and further requested the following information

1. The current mechanism of implementation of the said notification across the states.

• _ 2. The number of inspections conducted in veterinary medical shops and related establishments & their outcomes.

  3. Details of punitive actions initiated or completed against violators, if any, as part of enforcement.

ions conducted in veterinary medical shops and related establishments & their outcomes.

3. Details of punitive actions initiated or completed against violators, if any, as part of enforcement.

Further, it is requested to ensure that the above-referred drugs and their formulations are sold only to licensed manufacturers (bulk and formulation) for sale and distribution through licensed premises, only for the intended purpose, with proper reconciliation, and to take appropriate regulatory action incase of violations as the case may be under the Drugs & Cosmetics Act, 1940, and Rules 1945 thereunder.

In view of the above, you are requested to provide the information as sought by MPEDA in a time bound manner for further necessary action in the matter.

Encl - As above

==> picture [137 x 73] intentionally omitted <==

----- Start of picture text -----<br> Your faithfully,<br>fe<br>(Dr\ Rajeev Si Raghuvanshi)<br>Drugs Controller\General(India)<br>----- End of picture text -----<br>

Copy to:

1. PS to JS (R) Ministry of Health and Family Welfare

2. DGHS

3. MOEF & CC

4. IVRI & DAHD

5. All Zonal and sub zonal office of CDSCO -With request to co-ordinate with respective State /UT Durgs Controllers for forwarding their comments for further transmission to MPEDA.

6. Director, MPEDA